Skip to content

Ademtech vs LUMICKS

Ademtech logo

Ademtech

Superparamagnetic nanoparticles for life sciences and in-vitro diagnostics

29 employees · est. 2000 · Pessac, France

VS
LUMICKS logo

LUMICKS

See more. Know more

123 employees · est. 2014 · Amsterdam, The Netherlands

Ademtech is the older company (2000 vs 2014); LUMICKS is the larger of the two.

Side-by-Side Comparison

Ademtech LUMICKS
Founded
2000 older 2014
Headquarters
Pessac, France Amsterdam, The Netherlands
Employees
29 123 larger
Industry
Biotechnology, Life Sciences, Manufacturing Biotechnology, Life Sciences, Medical Devices
Funding Stage
Seed Debt Financing
Total Funding
Not tracked yet $77.85M
Funding Rounds
1 6
Services
Manufacture and supply of magnetic particles, DNA extraction and amplification kits, PCR kits for dermatomycoses detection, Forensic DNA analysis solutions, Automation equipment for laboratories dynamic single-molecule analysis, cell avidity analysis, real-time analysis tools
Target Customers
IVD industry professionals, Forensic laboratories, Molecular diagnostic labs, Biological and life sciences researchers academic researchers, pharmaceutical researchers, medical research institutions
Taxonomy
Superparamagnetic NanoparticlesIn Vitro DiagnosticsLife SciencesMicrofluidicsPolymer ChemistryCellular Biology +8 Life SciencesCell BiologyMolecular BiologySingle-Molecule AnalysisCell Avidity AnalysisOptical Tweezers +7
Website
ademtech.com lumicks.com
Ademtech logo

About Ademtech

Ademtech, founded in 2000, is a pioneering company in the arenas of Biotechnology, Life Sciences, Manufacturing, and Medical Devices. Headquartered in France, their focus lies in the development of superparamagnetic nanoparticles for life sciences and in-vitro diagnostics, leveraging groundbreaking...

LUMICKS logo

About LUMICKS

LUMICKS is a leading provider of dynamic single-molecule and cell avidity analysis instruments, aiming to empower scientists with tools that reveal crucial insights at the molecular and cellular level. Leveraging innovative and Nobel Prize-winning technologies, such as optical tweezers and STED supe...

Also comparing in this category

Comparing more than these two?

Get Ademtech, LUMICKS and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Ademtech compare?

A PDF of Ademtech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Ademtech was founded in 2000, based in Pessac, France, with 29 employees. Ademtech, founded in 2000, is a pioneering company in the arenas of Biotechnology, Life Sciences, Manufacturing, and Medical Devices. Headquartered in France, their focus lies in the development of su. LUMICKS was founded in 2014, based in Amsterdam, The Netherlands, with 123 employees. LUMICKS is a leading provider of dynamic single-molecule and cell avidity analysis instruments, aiming to empower scientists with tools that reveal crucial insights at the molecular and cellular level.
Ademtech has raised no disclosed funding and LUMICKS $77.85M. Latest stage: Ademtech Seed, LUMICKS Debt Financing.
Both work in Biotechnology, Life Sciences and Medical Devices and list life sciences, microfluidics and molecular biology among their focus areas.

Compare Ademtech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ademtech on 23 Nov 2025, and LUMICKS on 24 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout